Emily Tonorezos named head of NCI’s Office of Cancer Survivorship

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Emily S. Tonorezos was named director of the NCI Office of Cancer Survivorship.

Tonorezos joins NCI from Memorial Sloan Kettering Cancer Center and the Weill Cornell Medical College, where she was director of the Adult Long-Term Follow-Up Program for survivors of childhood and young adult cancers.

Her research focuses on cardiometabolic consequences of cancer therapy, childhood and young adult cancer survivorship, diet and nutrition, and care coordination for this population. She was also co-leader of the International Guideline Harmonization Group for the metabolic syndrome guidelines, and she led a recent international effort to develop recommendations for adult survivors of heritable retinoblastoma.

Tonorezos replaces interim director Deborah Mayer, who led the office after retirement of Julia Rowland,

Table of Contents


Companies vying for accelerated approval and devising strategies for confirmatory trials would be best served by seeking prospective sign-off from FDA, agency officials say.  Officials from the FDA Oncology Center of Excellence described these best practices in a perspective piece in the Sept. 21 issue of The New England Journal of Medicine and discussed the...